Overview

• The programme uses the existing 4CMenB meningococcal B vaccine off-label to provide 32.7%–42% protection against gonorrhoea cases.
• Clinics will target gay and bisexual men with multiple recent partners or bacterial STIs, plus other high-risk individuals, for the free gonorrhoea jab.
• Imperial College London modeling suggests the rollout could prevent up to 100,000 infections over the next decade, potentially saving the NHS more than £7.9 million.
• Gonorrhoea diagnoses in England reached a record 85,000 in 2023, raising alarms over growing ceftriaxone-resistant and extensively drug-resistant strains.
• Patients will also be offered mpox, HPV, and hepatitis A and B vaccines during the same appointments to bolster comprehensive sexual health protection.